Additionally, inhibitors of the protein kinase ATR, a regulator of homologous recombination with prolonged recruitment to telomere ends in the setting of ATRX mutation, have been found to selectively induce death of ALT-positive cancer cells [123]. The gene discussed is ATRX; the disease is cancer.